Skip to main content

and
  1. Article

    Open Access

    Pancreatic adenocarcinoma third line systemic treatments: a retrospective cohort study

    Chemotherapy for metastatic pancreatic adenocarcinoma (PDAC) primarily relies on FOLFIRINOX (LV5FU- irinotecan – Oxaliplatine) and Gemcitabine – Nab-Paclitaxel in the first-line setting. However, second-lines ...

    A. Gueiderikh, A. Tarabay, M. Abdelouahab, C. Smolenschi, M. L. Tanguy in BMC Cancer (2024)

  2. Article

    Open Access

    Small bowel adenocarcinoma phenoty**, a clinicobiological prognostic study

    Small bowel adenocarcinoma (SBA) is a rare tumour with a poor prognosis. Molecular biology data on SBA carcinogenesis are lacking.

    T Aparicio, M Svrcek, A Zaanan, E Beohou, A Laforest in British Journal of Cancer (2013)

  3. Article

    Open Access

    Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer

    The aim of our study was to evaluate the prognostic role of immunological microenvironnement in stage II–III CRC patients.

    N Chaput, M Svrcek, A Aupérin, C Locher, F Drusch, D Malka in British Journal of Cancer (2013)